Cytogen, Inc. (KOSDAQ:217330)
South Korea · Delayed Price · Currency is KRW 3,210.00
-15.00 (-0.47%)
At close: Oct 2, 2026
Cytogen Market Cap
Cytogen has a market cap or net worth of 74.24 billion as of October 2, 2026. Its market cap has increased by 25.46% in one year.
Market Cap
74.24B
Enterprise Value
66.44B
Revenue
27.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,210.00
ChartMarket Cap Chart
Since November 22, 2018, Cytogen's market cap has decreased from 87.89B to 74.24B, a decrease of -15.53%. That is a compound annual growth rate of -2.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 74.24B | -64.20% |
| Dec 30, 2025 | 207.40B | 98.24% |
| Dec 30, 2024 | 104.62B | -59.34% |
| Dec 28, 2023 | 257.28B | -11.12% |
| Dec 29, 2022 | 289.47B | -18.62% |
| Dec 30, 2021 | 355.72B | 47.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 232.78B |
| 3billion | 192.21B |
| GENINUS | 82.33B |
| GC Medical Science | 79.68B |
| Inventera | 76.77B |
| Protia | 76.38B |
| HLB Panagene | 56.00B |
| Seoulin Bioscience | 36.40B |